Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
KKR backs Premialab in $220m push into Middle East growth technology
KKR backs Premialab in $220m push into Middle East growth technology KKR has agreed to invest $220m in Premialab, a global provider of data, analytics, and risk management solutions for quantitative investing. The transaction marks the private equity firm’s first...
TPG reworks $600m Anastasia Beverly Hills investment through restructuring
TPG reworks $600m Anastasia Beverly Hills investment through restructuring TPG has exited most of its position in Anastasia Beverly Hills as part of a debt restructuring process, reducing its stake to around 6%, according to a Bloomberg report. The private equity firm...
Stone Point pilots $1bn evergreen fund to tap retail wealth capital
Stone Point pilots $1bn evergreen fund to tap retail wealth capital Stone Point Capital is piloting a new evergreen private equity fund of around $1bn, as it seeks to expand its reach into the retail wealth market, according to Bloomberg. The initiative reflects...